Prestige Consumer Healthcare Inc. (NYSE:PBH) Holdings Raised by Congress Asset Management Co.

Congress Asset Management Co. increased its stake in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 5.0% during the fourth quarter, HoldingsChannel reports. The firm owned 908,742 shares of the company’s stock after acquiring an additional 43,619 shares during the period. Congress Asset Management Co.’s holdings in Prestige Consumer Healthcare were worth $70,964,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of PBH. Martingale Asset Management L P raised its stake in shares of Prestige Consumer Healthcare by 0.4% during the 3rd quarter. Martingale Asset Management L P now owns 36,971 shares of the company’s stock worth $2,666,000 after purchasing an additional 140 shares in the last quarter. Horizon Kinetics Asset Management LLC raised its position in Prestige Consumer Healthcare by 4.8% during the third quarter. Horizon Kinetics Asset Management LLC now owns 3,247 shares of the company’s stock valued at $234,000 after acquiring an additional 150 shares in the last quarter. OLD National Bancorp IN grew its position in Prestige Consumer Healthcare by 4.4% in the third quarter. OLD National Bancorp IN now owns 3,974 shares of the company’s stock worth $287,000 after acquiring an additional 168 shares in the last quarter. Huntington National Bank grew its position in Prestige Consumer Healthcare by 39.9% in the third quarter. Huntington National Bank now owns 635 shares of the company’s stock worth $46,000 after acquiring an additional 181 shares in the last quarter. Finally, GAMMA Investing LLC increased its stake in shares of Prestige Consumer Healthcare by 18.9% during the 4th quarter. GAMMA Investing LLC now owns 1,383 shares of the company’s stock worth $108,000 after purchasing an additional 220 shares during the last quarter. Institutional investors and hedge funds own 99.95% of the company’s stock.

Prestige Consumer Healthcare Stock Performance

Shares of NYSE PBH opened at $85.62 on Friday. Prestige Consumer Healthcare Inc. has a 12 month low of $62.35 and a 12 month high of $88.36. The company has a quick ratio of 2.10, a current ratio of 3.68 and a debt-to-equity ratio of 0.56. The company has a market cap of $4.23 billion, a P/E ratio of 20.05, a P/E/G ratio of 2.43 and a beta of 0.50. The business’s 50 day moving average is $79.30 and its two-hundred day moving average is $76.01.

Prestige Consumer Healthcare (NYSE:PBH) last issued its quarterly earnings results on Thursday, February 6th. The company reported $1.22 earnings per share for the quarter, beating analysts’ consensus estimates of $1.18 by $0.04. Prestige Consumer Healthcare had a net margin of 19.13% and a return on equity of 12.36%. On average, equities analysts expect that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current year.

Analyst Upgrades and Downgrades

PBH has been the subject of a number of recent research reports. Canaccord Genuity Group upped their price objective on shares of Prestige Consumer Healthcare from $93.00 to $100.00 and gave the stock a “buy” rating in a report on Friday, February 7th. Raymond James raised Prestige Consumer Healthcare to a “moderate buy” rating in a report on Thursday, December 19th. StockNews.com upgraded Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a report on Friday, January 24th. Oppenheimer increased their price target on Prestige Consumer Healthcare from $87.00 to $93.00 and gave the company an “outperform” rating in a report on Thursday. Finally, DA Davidson boosted their price objective on shares of Prestige Consumer Healthcare from $95.00 to $104.00 and gave the stock a “buy” rating in a research note on Friday, February 7th. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $92.60.

Insider Buying and Selling

In other Prestige Consumer Healthcare news, CEO Ronald M. Lombardi sold 10,875 shares of the firm’s stock in a transaction that occurred on Tuesday, November 19th. The stock was sold at an average price of $82.60, for a total value of $898,275.00. Following the completion of the sale, the chief executive officer now owns 320,952 shares in the company, valued at approximately $26,510,635.20. This trade represents a 3.28 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.60% of the stock is owned by company insiders.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.